In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 35 for your search:
Drug:  keyhole limpet hemocyanin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1694, CAN-NCIC-ME9, MDA-DM-E1694, MSKCC-96008, SWOG-9512, CAN-NCIC-E1694, MSKCC-E1694, SWOG-E1694, E1694, ME9

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BIOMIRA-STn-BR-104, NCI-V98-1489, NCT00003638

3.

Phase: Phase III
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: INTRACEL-BCI-9804-04, NCT00006034

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GENITOPE-G2000-03, CUMC-0101-142, UCLA-0010061, NCT00017290

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-94078, NCI-H94-0538

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UR0414, NCT00197860

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: MM0413, NCT00197912

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ERLANGEN-DERMA-ER-DC-06, CDR0000343699, EU-20317, NCT00074230

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-96-C-0133, CRB-9309, NCI-T93-0164N, T93-0164, NCT00878488

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: UNMC-04094, NCI-V94-0589

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: under 60
Sponsor: NCI
Protocol IDs: NCI-97-C-0030B, CRB-9407, NCI-T94-0085N, T94-0085

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000064244, NCI-97-C-0033B, NCI-T94-0094N, CRB-9409, T94-0094, NCT00019097

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: NCI, NHLBI
Protocol IDs: NHLBI-T96-0017, NCI-T96-0017N, T96-0017

14.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-98002, NCI-G98-1440

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: 197-99, P30CA036727, UNMC-197-99, GENITOPE-9902, SUMC-9902, NCT00004197

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: 196-99, P30CA036727, UNMC-196-99, GENITOPE-9901, NCT00004198

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-98065, NCI-H99-0047, NCT00004249

18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 000133, 00-C-0133, NCI-00-C-0133, NCI-1033, NCT00020215, NCT00005780

19.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: 000201, 00-C-0201, NCI-00-C-0201, NCI-1029, 1029, NCT00020306, NCT00006184

20.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FAV-ID-01, SKCC-2001, SKCC-BB-IND-8786

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor:
Protocol IDs: MSKCC-91095, NCI-V91-0167

22.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-92100, NCI-V92-0144

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-92168, NCI-V93-0228

24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-92169, NCI-V93-0229

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UARK 2000-46, NCT00083538
1   
New Search